IRIS
CIABATTONI, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.555
AS - Asia 4.287
EU - Europa 4.128
SA - Sud America 393
Continente sconosciuto - Info sul continente non disponibili 257
AF - Africa 51
OC - Oceania 4
Totale 15.675
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.438
SG - Singapore 1.664
CN - Cina 1.219
UA - Ucraina 814
TR - Turchia 646
IE - Irlanda 606
GB - Regno Unito 568
SE - Svezia 506
RU - Federazione Russa 498
FR - Francia 345
BR - Brasile 328
DE - Germania 316
VN - Vietnam 285
FI - Finlandia 200
IN - India 191
IT - Italia 176
BD - Bangladesh 76
CA - Canada 50
MX - Messico 40
HK - Hong Kong 36
AR - Argentina 26
PL - Polonia 22
KR - Corea 21
ZA - Sudafrica 21
IQ - Iraq 19
CZ - Repubblica Ceca 15
ID - Indonesia 15
PK - Pakistan 15
ES - Italia 14
JP - Giappone 14
NL - Olanda 12
SA - Arabia Saudita 11
EC - Ecuador 10
EU - Europa 9
IL - Israele 9
AT - Austria 8
PH - Filippine 8
UZ - Uzbekistan 8
IR - Iran 7
VE - Venezuela 7
CO - Colombia 6
JO - Giordania 6
LT - Lituania 6
MA - Marocco 6
CR - Costa Rica 5
DZ - Algeria 5
EG - Egitto 5
HN - Honduras 5
KE - Kenya 5
AE - Emirati Arabi Uniti 4
JM - Giamaica 4
LB - Libano 4
OM - Oman 4
PY - Paraguay 4
QA - Qatar 4
TW - Taiwan 4
UY - Uruguay 4
AL - Albania 3
AU - Australia 3
BE - Belgio 3
BO - Bolivia 3
KG - Kirghizistan 3
NI - Nicaragua 3
RO - Romania 3
SY - Repubblica araba siriana 3
TN - Tunisia 3
BB - Barbados 2
BG - Bulgaria 2
CI - Costa d'Avorio 2
CL - Cile 2
GD - Grenada 2
KZ - Kazakistan 2
MY - Malesia 2
PA - Panama 2
PE - Perù 2
SV - El Salvador 2
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BW - Botswana 1
BY - Bielorussia 1
CH - Svizzera 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
IM - Isola di Man 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
MD - Moldavia 1
MK - Macedonia 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
Totale 15.425
Salva come PNG Salva come JPEG
Città #
Singapore 1.248
Jacksonville 857
San Jose 743
Chandler 740
Dublin 602
Southend 454
Ashburn 358
Beijing 322
Princeton 314
Izmir 311
Dallas 242
Council Bluffs 240
Nanjing 202
Santa Clara 189
Wilmington 184
Los Angeles 159
Cambridge 143
Dearborn 132
Tongling 107
Ho Chi Minh City 94
Munich 83
Buffalo 82
New York 81
The Dalles 76
Nanchang 74
Woodbridge 68
Moscow 66
Hanoi 61
Ann Arbor 60
Boardman 58
Shenyang 45
Altamura 40
São Paulo 35
Hebei 34
Kunming 34
Tianjin 34
Grevenbroich 33
Washington 33
Helsinki 30
Hong Kong 30
Houston 29
Changsha 28
Jiaxing 28
Turku 28
Brooklyn 27
Norwalk 24
Denver 22
Orem 21
Chennai 20
Seoul 20
Montreal 19
Phoenix 19
Haiphong 18
Hangzhou 18
Atlanta 17
Redondo Beach 17
Warsaw 17
Da Nang 16
Hefei 16
Augusta 15
Chieti 15
Mexico City 15
Orange 15
Chicago 14
Columbus 14
Falls Church 14
Poplar 14
Tokyo 14
Frankfurt am Main 13
Jinan 13
Johannesburg 13
San Mateo 13
Boston 12
Seattle 12
Toronto 11
Baghdad 10
Brno 10
San Francisco 10
Rome 9
Stockholm 9
Belo Horizonte 8
Changchun 8
Lanzhou 8
Rio de Janeiro 8
Zhengzhou 8
Auburn Hills 7
Brasília 7
Leawood 7
Mumbai 7
Amsterdam 6
Ankara 6
Biên Hòa 6
Charlotte 6
Guayaquil 6
London 6
Manchester 6
Milan 6
Querétaro 6
Roubaix 6
Shanghai 6
Totale 9.501
Salva come PNG Salva come JPEG
Nome #
In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. 200
Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus 192
Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration. 175
Amylin inhibits hypothalamic dopamine release. 161
Platelet Cyclooxygenase Inhibition by Low-Dose Aspirin Is Not Reflected Consistently by Platelet Function Assays. Implications for Aspirin "Resistance" 159
Determinants of platelet activation in hypertensives with microalbuminuria. 156
Chromatin derived acid peptides inhibit dopamine and norepinephrine release in the hypothalamus. 154
A Polymorphism in the Cyclooxygenase 2 Gene as an Inherited Protective Factor Against Myocardial Infarction and Stroke 153
Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus 153
Soluble CD40L in Mediterranean Spotted Fever: relation to oxidative stress and platelet activation 152
Aging increases amyloid beta-peptide-induced 8-iso-prostaglandin F2alpha release from rat brain. 151
Effect of CART peptide-(55-102), leptin and orexin-B on hypothalamicserotonin release. 148
Helicobacter pylori infection causes persistent platelet activation in vivo through enhanced lipid peroxidation 145
Anterior pituitary cell production of 8-iso-prostaglandin F2alpha. 144
Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. 144
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays. implications for aspirin 'resistance'. 144
Cyclooxygenase-1, but not -2, is upregulated in NB4 leukemic cells and human primary promyelocytic blasts during neutrophil granulocytic differentiation and contributes to maturation. 144
Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins. 141
The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy. 141
8-Isoprostane in exhaled breath condensate (EBC)and excercise-induced bronchoconstriction in asthmatic children and adolescents 140
Decreased in vivo oxidative stress and decreased platelet activation following metformin treatment in newly diagnosed type 2 diabetes subjects 138
Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins. 138
Abnormal pH-sensing of platelet Na+/H+ exchanger in patients with cardiac syndrome X 137
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) sequentially upregulates nitric oxide and prostanoid production in primary human endothelial cells. 136
Effects of vitamin E supplementation on F2-isoprostane and thromboxane biosynthesis in healthy cigarette smokers. 136
Decreased plasma soluble rage in patients with hypercholesterolemia: effects of statins. 135
Insulin resistance as a determinant of platelet activation in obese women. 133
Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. 132
Vitamin E inhibits enhanced F2 isoprostane biosynthesis in type IIA hypercholesterolemia 130
Circulating MRP 8/14 is Associated with Thromboxane Dependent Platelet Activation in NSTEMI Patients: Effect of Aspirin Treatment 128
Increased thromboxane biosynthesis in essential thrombocythemia 127
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 127
Determinants of thromboxane biosynthesis in rheumatoid arthritis: Role of RAGE and oxidant stress. 127
Platelet Activation and Lipid Peroxidation in Patients With Acute Ischemic Stroke. 126
Immunological characterization uf urinary 8-epi-prostaglandin f2alfa excretion in man 125
Determinants of platelet activation in hypertensives with microalbuminuria. 125
Problemi di metodologia per la individuazione del rischio tossicologico. Consiglio Nazionale delle Ricerche 124
Soluble RAGE in type 2 diabetes: association with oxidative stress. 124
Inhibition of thromboxane biosynthesis by triflusal in type 2 diabetes mellitus. 124
Association between PAI-1 and Oxidative Stress in Android Obesity 124
In vivo formation of 8-epi-prostaglandin F2alpha in diabetes mellitus. Effects of tight metabolic control and vitamin E supplementation 124
Platelets as a source of CD40 ligand in type 2 diabetes mellitus 123
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance". 122
Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with type II diabetes mellitus. 121
In vivo formation of 8-Epi-prostaglandin F2 alpha is increased in hypercholesterolemia. 120
Decreased plasma levels of soluble receptor for advanced glycation end products in type 2 diabetes mellitus: association with oxidative stress and metabolic control. 120
Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed platelets. 118
Attivazione piastrinica e stress ossidativo in vivo nell’artrite reumatoide. 118
Role of Platelet Activation in Dementia 117
Acute effects of air pollution on pulmonary function, airway inflammation, and oxidative stress in asthmatic children. 117
Determinants of platelet activation in Alzheimer's disease 117
In vivo formation of 8-epi-prostaglandin F2alpha in diabetes mellitus. Effects of tight metabolic control and vitamin E supplementation. (pubbl su Suppl Thromb Haemostas) 116
Drugs, prostaglandins, and renal function. 116
Postprandial hyperglycemia is an important determinant of platelet activation. evidence from biochemical measurements and pharmacological intervention with acarbose 116
Differential Expression and Regulation of Cyclooxygenase Isozymes in Thymic Stromal Cells. 116
In vivo formation of 8-epi-prostaglandin F2alpha in increased in hypercholesterolemia. An aspirin-insensitive amplification mechanism of platelet activation (pubbl su Suppl Thromb Haemostas) 115
Anaphylaxis increases 8-iso-PGF2alpha release from guinea-pig lung in vitro 115
Effects of anthracyclines on hypothalamic dopamine release. 115
Thromboxane-dependent CD40L release in type 2 diabetes mellitus 114
Postprandial hyperglycemia is an important determinant of platelet activation in early type 2 diabetes mellitus. Evidence from biochemical measurements and pharmacological intervention with acarbose. 114
Measurement of 8-isoprostane in exhaled breath condensate. 113
Tachykinin-eicosanoid crosstalk in airway inflammation 112
Insulin resistance as a determinant of platelet activation in obese women 112
Effects of cocaine- and amphetamine-regulated transcript peptide, leptin and orexins on hypothalamic serotonin release. 111
Determinants of Platelet Activation in Heart Failure. 110
Platelet activation in obese women: role of inflammation and oxidant stress. 109
Exhaled 8-Isoprostane as an In Vivo Biomarker of Lung Oxidative Stress in Patients with COPD and Healthy Smokers 108
Increased exhaled 8-isoprostane in childhood asthma. 108
Effects of Acarbose on in Vivo Markers of Oxidative Stress and Platelet Activation in Early Type 2 Diabetes 108
Determinants of Thromboxane-Dependent Platelet Activation in Heart Failure. 108
Effect of gherlin and amylin on hypothalamic dopamine, norepinephrine and serotonin release. 107
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 107
Effects of Acarbose on in Vivo Markers of Oxidative Stress and Platelet Activation in Early Type 2 Diabetes. 106
Decreased plasma levels of soluble receptor for advanced glycation end products in type 2 diabetes mellitus: association with oxidative stress and metabolic control 106
In vivo formation of 8-EPI-prostaglandin F2 alpha in diabetes mellitus. Effects of tight metabolic control and vitamin E supplementation 105
Enhanced Lipid Peroxidation and Platelet Activation as Potential Contributors to Increased Cardiovascular Risk in the “Low-HDL” Phenotype 103
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 103
Decreased plasma levels of soluble receptor for advanced glycation end products in type 2 diabetes mellitus: association with oxidative stress and metabolic control 102
Induced sputum, exhaled breath condensate and nasal lavage fluid in electroplating workers exposed to chromium 101
Soluble CD40L in Mediterranean Spotted Fever: Relation to oxidative stress and platelet activation. 101
Platelet Activation Markers in Patients with Peripheral Arterial Disease. A Prospective Comparison of Different Platelet Function Tests 101
Validation of leukotriene B4 measurements in exhaled breath condensate. 100
Modulation of the expression and activity of cyclooxygenases in normal and accelerated erytrhopoiesis. 100
Fluvastatin reduces soluble P-selectin and ICAM-1 levels in hypercholesterolemic patients: role of nitric oxide 99
Identification of 8-iso-prostaglandin (PG) F2alfa in rat brain neuronal endings: a possible marker of membrane phospholipid peroxidation. 98
Abnormally high thromboxane biosynthesis in homozygous homocystinuria. Evidence for platelet involvement and probucol-sensitive mechanism 98
Determinants of Platelet Activation in Heart Failure. 98
Effects of montelukast treatment and withhdrawal on fractional exhaled nitric oxide and lung function in children with asthma 97
Identification of 8-iso-prostaglandin F2alpha in rat brain neuronal endings: a possible marker of membrane phospholipid peroxidation. 97
Effects of atorvastatin and rosuvastatin on throboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. 97
Soluble CD40L as an indicator of platelet Activation in Heart Failure 97
Oxidative stress and platelet activation in children and adolescents with type 1 diabetes: role of interleukin-6 97
In vivo formation of 8-iso-prostaglandin F2a and aspirin-insensitive thromboxane biosynthesis in unstable angina 96
Increased macrothrombocytopenia with distinctive platelet ultrastructural and functional features 95
Enhanced lipid peroxidation and platelet activation in the early stages of type 1 diabetes mellitus. Role of Interleukin-6 and disease duration. 95
Abnormally high thromboxane biosynthesis in homozygous homocystinuria. Evidence for platelet involvement and probucol-sensitive mechanism 95
Inherited Macrothrombocytopenia with Distinctive Platelet Ultrastructural and Functional Features 94
Signaling pathways involved in lipopolysaccharide stimulation of prostaglandin production by rat hypothalamic astroglial cells 94
Prognostic significance of cyclooxygenase-2 in laryngeal squamous cell carcinoma. 94
Low-density lipoprotein level reduction by the 3-hydroxy-3-methylglutaryl coenzima-A inhibitor sinvastatin is accompanied by a related reduction of F2-isoprostane formation in hypercholesterolemic subjects: no further effect of vitamin E. 94
Totale 12.123
Salva come PNG Salva come JPEG
Categoria #
all - tutte 61.199
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.199
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022581 0 7 4 118 71 9 11 43 45 11 78 184
2022/20231.930 159 197 126 222 189 447 115 134 233 19 39 50
2023/2024801 62 33 60 22 48 256 216 25 2 7 9 61
2024/20252.395 149 524 484 28 19 55 20 91 174 64 277 510
2025/20264.393 429 255 407 464 423 299 801 213 470 364 192 76
2026/2027361 110 251 0 0 0 0 0 0 0 0 0 0
Totale 15.675